Toll-like receptors (TLRs) are vital components of the immune system, acting as sentinels that detect and respond to ...

Some megatrends in health care are occurring that deserve our attention. We already know that as much as one-third of the U.S ...

Discover how your diet can improve vision health with essential nutrients, carotenoids, and food pairings for long-term eye ...

4D Molecular Therapeutics is axing two clinical programs and cutting off funds for three other assets, with resources to be ...

The adenine base editor corrected the most common mutation associated with Stargardt disease in the ABCA4 gene with no off-target effects.

Macular degeneration is a prevalent eye disorder that typically results in loss of vision in individuals who are 50 years of age and older. Although there isn’t a recognized cure for this ...

For the past several years, the halls of the Las Vegas Convention Center have been lousy with AR/VR/XR smart glasses. While ...

SolidddVision smartglasses, which correct vision for people living with vision loss due to macular degeneration, will debut at CES.

BMO Capital analyst Kostas Biliouris downgraded the rating on 4D Molecular Therapeutics (FDMT – Research Report) to a Hold today, setting a ...

City Therapeutics has inked a new deal with Bausch + Lomb for a gene silencing approach to the eye disorder geographic ...

Soliddd, an optical and vision technology company, will debut the beta headset version of its virtual reality smart glasses ...

Under the terms of the option agreement, which was signed in December 2024, Bausch + Lomb has secured the exclusive option to acquire InflammX Therapeutics during an agreed-upon option period based on ...